Allo vs Hypomethylating/Best Supportive Care in MDS (BMTCTN1102)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mary Horowitz, MD, MS
Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
37 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope National Medical Center
Duarte, California, United States
- Stanford Hospital and Clinics
Stanford, California, United States
- University of Florida College of Medicine
Gainesville, Florida, United States
- H. Lee Moffitt Cancer Center
Tampa, Florida, United States
- Emory University
Atlanta, Georgia, United States
- University of Chicago
Chicago, Illinois, United States
- University of Kansas Hospital
Kansas City, Kansas, United States
- University of Kentucky
Lexington, Kentucky, United States
- Johns Hopkins
Baltimore, Maryland, United States
- University of Maryland Medical Systems - Greenebaum Cancer Center
Baltimore, Maryland, United States
- Dana Farber Cancer Institute/brigham & Women'S
Boston, Massachusetts, United States
- Dana Farber Cancer Institute/massachusetts General Hospital
Boston, Massachusetts, United States
- Karmanos Cancer Institute/bmt
Detroit, Michigan, United States
- Mayo Clinic - Rochester
Rochester, Minnesota, United States
- Washington University/barnes Jewish Hospital
St Louis, Missouri, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Mount Sinai Hospital
New York, New York, United States
- University of North Carolina
Chapel Hill, North Carolina, United States
- University of North Carolina Hospital at Chapel Hill
Chapel Hill, North Carolina, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
- Jewish Hospital Bmt Program
Cincinnati, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- University Hospitals of Cleveland/ Case Western
Cleveland, Ohio, United States
- Ohio State/arthur G. James Cancer Hospital
Columbus, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Baylor College of Medicine/the Methodist Hospital
Houston, Texas, United States
- University of Texas/md Anderson Crc
Houston, Texas, United States
- University of Utah Med School
Salt Lake City, Utah, United States
- Virginia Commonwealth University Mcv Hospitals
Richmond, Virginia, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- West Virginia University Hospital
Morgantown, West Virginia, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 16 Dec 2013
- Primary completion
- 5 Oct 2021
- Completion
- 5 Oct 2021
- Last update posted
- 3 Mar 2023
- Registered enrollment
- 384
- Registry id
- NCT02016781
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.